Tamiflu User Severe Reaction
Tamiflu User Has Severe Reaction. A 19-year-old British girl treated with Tamiflu has developed Stevens-Johnson syndrome and toxic epidermal necrolysis. The woman, Samantha Millard, was put on life support within 72 hours of taking ‘Tamiflu’, and is now blind. Stevens-Johnson syndrome and toxic epidermal necrolysis are … [Read more...]
Tamiflu Dosing Error Warning Issued by FDA
Tamiflu Dosing Error Warning. The U.S. Food & Drug Administration (FDA) has issued a Public Health Alert advising pharmacists and pediatrics healthcare professionals about potential dosing errors with Tamiflu (oseltamivir) for Oral Suspension. The FDA stated that U.S. health care providers typically write … [Read more...]
Relenza Side Effects Probes
Health Canada is looking into reports that Relenza, a drug used to treat the flu, has been linked to deaths and abnormal behavior in children. In November 2007, a US Food & Drug Administration (FDA) advisory panel had recommended stronger warnings about psychiatric side effects be added to the labeling of Relenza and another … [Read more...]
Tamiflu Resistant Flu More Common
Some current influenza viruses are carrying a mutation—A/H1N1-H274Y—that makes them resistant to Tamiflu. The Centers for Disease Control and Prevention (CDC) estimate that a small sampling of flu viruses nationwide carry the mutation. The Tamiflu resistant mutation has occurred in A/H1N1, one of the main circulating strains causing … [Read more...]
Tamiflu and Relenza Stronger Warnings
Tamiflu and Relenza, drugs used to treat the flu, should bear warnings about possible psychiatric side effects, a Food & Drug Association (FDA) panel said yesterday. The recommendation came in the wake of a number of reports that both Tamiflu and Relenza had been linked to episodes of abnormal behavior that included delirium … [Read more...]
New Tamiflu Warning
New Warning Regarding Tamiflu. The popular antiviral drug Tamiflu is under fire again, this time from Health Canada. The Canadian government issued a new safety advisory today, warning consumers that Tamiflu may be linked to hallucinations and abnormal behavior, including self harm. In conjunction with the new warning, Health … [Read more...]
FDA Tamiflu Behavior Warning
Tamiflu To Carry Behavior Warning. Food and Drug Administration staff recommend that the label for Roche Holding AG's (RHHBY) flu drug Tamiflu be updated to include a precaution related to possible psychiatric problems in patients who take it. The staff's recommendation, posted on the FDA's Web site Monday, follows a 10-month … [Read more...]
